The project aims to facilitate the identification of public innovation needs, conduct market consultations to identify market capabilities and potential solutions, and help public buyers tap into the innovative capacity of SMEs. The project will enhance the capacity of Public Authorities to engage in cross-border PPI for circular solutions and establish a focal point for engagement between Europe’s leading innovation ecosystems and ambitious public authorities interested in leveraging cross- border PPI to accelerate the circular economy.

P5 Innobroker stands for “Public Private Partnership for Public Procurement" of Innovation within the Innobroker Model. It expresses the goal to further develop, accelerate, deploy, validate and demonstrate a self-sustainable EU-wide B2G Public Procurement of Innovation (PPI) brokerage service ecosystem-based business model and platform (Innobroker) for mobilizing and bringing together early adopter public buyers and leading-edge EU SMEs and start-ups as well as to pave the way for the implementation of an effective, collaborative/coordinated set of transnational SMEs/start-up-oriented PPI bids through a Public-Private Partnership PPI Facilitator Business Model (P5 Innovation Procurement broker).

ProCirc is set up to experiment, implement and learn how circular economy and procurement can benefit the region. To fully benefit from circular opportunities and to contribute to the international development of circular economy, ProCirc conducts and supports 30 pilots to demonstrate procurement opportunities. Each pilot aims to reduce 20-25% raw materials, waste and CO2 emissions. Insights and tools regarding specific sectors like construction, furniture and ICT will be disseminated in the North Sea region by creating an active transnational network on the topic.

Impact

Procuring organisations can stimulate circular economy using their demand to change markets. This will not only have a direct impact on the business models; innovation and economic opportunities that suppliers will create, but also on decreasing carbon emissions and the use of resources and closing product and material loops.

Learn more

InnoBuyer is a project that aims to become a testing ground and benchmark towards the implementation of a demand-driven methodology that brings together public and private organisations (Challengers) and innovative companies (Solvers) to jointly co-create innovative solutions, and speed-up the process leading to a concrete innovation procurement. This project has received funding from the European Union’s Horizon Europe research and innovation programme under the Grant Agreement 101071212.

The DrugDetect project aims to procure an innovative solution for the automatic detection of a large range of drugs in correctional institutions and prisons, that is available 24/7, does not cause delays in internal processes, does not require minimal human intervention, and is GDPR compliant. DrugDetect has been co-funded by the COSME programme of the European Union under grant agreement No 101036225

The RaDAR project aims to address the European urgent need of a rapid detection and effective infection control system for antimicrobial resistance (AMR) through the implementation of a value-based cross-border collaborative procurement of innovative solutions. The RaDAR project aims to address the European urgent need of a rapid detection and effective infection control system for antimicrobial resistance (AMR) through the implementation of a value-based cross-border collaborative procurement of innovative solutions. 

This project has received funding from the COSME Programme of the European Union, Grant Agreement N° 101036228

The ECOQUIP+ project aims to demonstrate how innovation procurement methods help to improve the efficiency, quality and sustainability of healthcare. This includes direct interventions in the procurement processes of individual hospitals in a number of EU Member States. At the heart of the EcoQUIP+ project are the six leader-led innovation procurement projects, each of which address a particular healthcare challenge.